NHC (NYSE: NHC) awards 1,458 restricted shares to senior counsel

Rhea-AI Filing Summary

National Healthcare Corp reported that Senior VP & General Counsel Josh A. McCreary acquired 1,458 shares of common stock on a restricted basis. These restricted shares vest over three years, in equal 33 1/3% installments on January 1 of 2027, 2028, and 2029. Following this grant, he directly holds 11,400 common shares, along with multiple option awards to purchase common stock reported as existing holdings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McCreary Josh A

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TN 37130

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior VP & General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		1,458(1)	A	$0	11,400	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$53.94							03/08/2024	03/08/2028	Common Stock	4,000		4,000	D
Option to Purchase Common Stock	$94.1							03/05/2025	03/05/2029	Common Stock	8,000		8,000	D
Option to Purchase Common Stock	$90.62							02/24/2026	02/24/2030	Common Stock	13,500		13,500	D
Option to Purchase Common Stock	$157.13							02/23/2027	02/23/2031	Common Stock	14,000		14,000	D

Explanation of Responses:

1. Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029.

	/s/ Josh McCreary	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did NHC disclose for Josh A. McCreary?

National Healthcare Corp disclosed that Senior VP & General Counsel Josh A. McCreary received a grant of 1,458 restricted shares of common stock. The award reflects equity-based compensation rather than an open-market purchase or sale and increases his directly held common stock position.

How do the newly granted NHC restricted shares vest for Josh A. McCreary?

The 1,458 restricted shares vest over three years in equal installments of 33 1/3% each. Vesting dates are January 1, 2027, January 1, 2028, and January 1, 2029, subject to the grant’s stated vesting conditions remaining satisfied over time.

How many NHC common shares does Josh A. McCreary hold after this Form 4?

After this equity award, Josh A. McCreary directly holds 11,400 shares of National Healthcare Corp common stock. This total reflects his position following the grant of 1,458 restricted shares reported in the filing as a stock-based compensation award.

Were any NHC shares sold by Josh A. McCreary in this Form 4 filing?

No share sales are reported in this Form 4 for Josh A. McCreary. The filing shows only an acquisition in the form of a 1,458-share restricted stock grant, along with updates to his existing option holdings as of the transaction date.

What option holdings in NHC stock are reported for Josh A. McCreary?

The filing lists several direct holdings of options to purchase National Healthcare Corp common stock. Reported post-transaction balances include 4,000, 8,000, 13,500, and 14,000 options, reflecting separate option grants and their outstanding amounts as of February 27, 2026.